Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Negative Symptoms and Social Cognition in Schizophrenia
NCT03662425Completed
- Sponsor
- Shanghai Mental Health Center
- Start
- Jul 2018
- Primary completion
- Mar 2020
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin nasal spray in schizophrenia (2 arms), sponsored by Shanghai Mental Health Center. Primary endpoints: Positive and Negative Syndrome Scale at 2 weeks and Clinical Assessment Interview for Negative Symptoms at 2 weeks. Started Jul 2018; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03662425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03662425.